Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory mediators in equine synovial fluid

K T Gibson1, H Hodge, T Whittem

  • 1Department of Veterinary Clinical Sciences, Massey University, Palmerston North, New Zealand.

Australian Veterinary Journal
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of Moxidectin in Bare-Nosed Wombats (Vombatus ursinus) After Intravenous, Sub-Cutaneous and Transdermal Administration.

Journal of veterinary pharmacology and therapeutics·2026
Same author

Observations on the use of a pain numbing device for repetitive percutaneous sampling in sheep.

Australian veterinary journal·2021
Same author

A randomised controlled masked clinical trial of two treatments for osteoarthritis in dogs.

Australian veterinary journal·2021
Same author

A pilot study of 4CYTE™ Epiitalis® Forte, a novel nutraceutical, in the management of naturally occurring osteoarthritis in dogs.

Australian veterinary journal·2020
Same author

Population physiologically based modeling of pirlimycin milk concentrations in dairy cows.

Journal of dairy science·2020
Same author

Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics.

Journal of veterinary pharmacology and therapeutics·2017

Prostaglandin E2 (PGE2) levels were significantly higher in horses with joint disease compared to healthy horses. Other inflammatory mediators showed no significant differences, suggesting PGE2 is a key indicator in equine joint inflammation.

Area of Science:

  • Equine medicine
  • Inflammatory mediators
  • Joint disease research

Background:

  • Degenerative joint disease and chip fractures are common in horses.
  • Inflammatory mediators play a crucial role in joint pathology.
  • Understanding these mediators can aid in diagnosis and treatment.

Purpose of the Study:

  • To compare concentrations of inflammatory mediators in synovial fluid.
  • To investigate differences between healthy equine joints and those affected by disease.
  • To identify key inflammatory markers in equine joint disease.

Main Methods:

  • Enzyme immunoassay for prostaglandin E2 (PGE2).
  • Radioimmunoassays for prostaglandin F2 alpha (PGF2 alpha), 6-keto-PGF1 alpha, and leukotriene B4 (LTB4).

Related Experiment Videos

  • Analysis of synovial fluid from normal and affected equine joints.

    • Main Results:

    • Significantly greater concentrations of PGE2 were found in affected joints.
    • No significant differences were observed in PGF2 alpha, 6-keto-PGF1 alpha, or LTB4 levels.
    • PGE2 emerged as a potential indicator of equine joint inflammation.

    Conclusions:

    • Prostaglandin E2 is elevated in horses with degenerative joint disease or chip fractures.
    • Other measured mediators (PGF2 alpha, 6-keto-PGF1 alpha, LTB4) do not show significant changes.
    • PGE2 may serve as a valuable biomarker for equine joint inflammation.